Viewing Study NCT07139405

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 3:23 AM
Ignite Modification Date: 2026-01-31 @ 8:56 PM
Study NCT ID: NCT07139405
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-08-24
First Post: 2025-08-17
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: TRIGLYTZA® VERSUS METFORMIN IN OBESE ADULT TYPE 2 DIABETES (T2DM) PATIENTS OVER 24 WEEKS OF TREATMENT
Sponsor: Myopharm Limited
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Type 2 Diabetes (T2DM) View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Type 2 Diabetes View
None Diabetes View
None Metformin View
None Myopharm View
None Valsartan View
None Celecoxcib View